My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success.
How interviews are being conducted during this timeConsidering the travel bans and limited access, what other activities should MSLs be focusing on during the pandemic?Skills mandatory for MSLs during and after the crisis to find successHow has COVID 19 affected the hiring landscape and what is expected to happen in the upcoming months/yearHow will HCP expectations change as a result of CovidHow an MSL can meet or exceed expectations during the pandemicHow does Paul expect Pharma to change practices as a result of Covid-19The advice Paul can give to MSLs to help aid in their success(0:00) Introduction of Paul Ward and episode focus
(0:41) Paul Ward's background and current role
(2:20) Impact of COVID-19 on MSLs' personal and professional lives
(4:46) MSL responsibilities and HCP interactions during the pandemic
(10:02) Challenges and strategies for virtual MSL engagements
(15:21) Future of virtual interactions in the MSL role
(19:59) Developing skills for effective virtual interactions
(24:00) HCP and patient expectations from MSLs during and post-COVID-19
(26:01) MSL performance metrics and expectations
(28:40) Quantitative vs. qualitative metrics for MSLs
(31:19) Changing patient expectations and healthcare dynamics
(34:21) Advice for MSLs to adapt and add value
(36:25) Impact of COVID-19 on MSL recruitment and hiring
(39:13) Future outlook for MSL roles and medical affairs
(40:11) Closing remarks and subscription reminder